A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa

Venugopal, Supriya S., MBBS, MMed (Clin Epi) ; Yan, Wenfei, MD, PhD ; Frew, John W., MBBS, MMed (Clin Epi) ; Cohn, Heather I., MD, PhD ; Rhodes, Lesley M., RN ; Tran, Kim, MBBS, FRCPA ; Melbourne, Wei, MD, MSc ; Nelson, Janis A., RPh, MPharm ; Sturm, Marian, PhD ; Fogarty, Janice, RN ; Marinkovich, M. Peter, MD ; Igawa, Satomi, MD ; Ishida-Yamamoto, Akemi, MD, PhD ; Murrell, Dedee F., MA, BMBCh, MD, FACD

Journal of the American Academy of Dermatology, 2013-12, Vol.69 (6), p.898-908.e7 [Periódico revisado por pares]

United States: Mosby, Inc

Texto completo disponível